TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,910,000 | -0.7% | 404,159 | 0.0% | 1.57% | +14.7% |
| Q4 2017 | $2,930,000 | +40.8% | 404,159 | 0.0% | 1.37% | +41.8% |
| Q3 2017 | $2,081,000 | +17.0% | 404,159 | 0.0% | 0.97% | -22.7% |
| Q2 2017 | $1,778,000 | +177.4% | 404,159 | +288.0% | 1.25% | +280.8% |
| Q1 2017 | $641,000 | +17.2% | 104,159 | +7.6% | 0.33% | -16.3% |
| Q4 2016 | $547,000 | -54.1% | 96,759 | +19.8% | 0.39% | -54.4% |
| Q3 2016 | $1,193,000 | +64.6% | 80,759 | 0.0% | 0.86% | +37.7% |
| Q2 2016 | $725,000 | – | 80,759 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |